HROW as of Nov 2 · 04:05 ET
HROWNasdaqPharmaceutical Preparations
Harrow, Inc. · Brief
Next report
7 days
Nov 9 · after closeest.Q3 FY26
Expected move
Inputs3 of 8≥ implied
- avg implied
- ±14.6%
- avg realized
- ±11.3%
Mar 27 '25±14.1%▼−5.96%×0.42
May 8 '25±18.6%▲+3.43%×0.18
Aug 11 '25±16.7%▲+3.23%×0.19
Q3 FY25±17.2%▲+13.47%×0.78
Feb 2 '26±9.2%▲+9.67%×1.05
Q1 FY26±15.1%▼−27.96%×1.85
May 11 '26±12.6%▼−23.69%×1.88
Q2 FY26±13.4%▼−3.14%×0.23
quarterimplied−30%0+30%realized×
Q2 FY26±13.4%▼−3.14%×0.23
May '26±12.6%▼−23.69%×1.88
Q1 FY26±15.1%▼−27.96%×1.85
Feb '26±9.2%▲+9.67%×1.05
Q3 FY25±17.2%▲+13.47%×0.78
Aug '25±16.7%▲+3.23%×0.19
2 older reports
May '25±18.6%▲+3.43%×0.18
Mar '25±14.1%▼−5.96%×0.42
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2 of 3
+0.66%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
HROW report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.